Rosen Law Firm has filed a securities class action lawsuit on behalf of investors who purchased American Depositary Shares (ADS) of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023, and December 26, 2025. Investors interested in serving as lead plaintiff must file a motion with the court by April 6, 2026.
The firm encourages affected shareholders to seek legal counsel promptly to protect their rights in this ongoing litigation.
**Why this matters**
This class action provides an opportunity for Mereo BioPharma investors who may have experienced losses during the specified period to participate in potential recovery efforts. Meeting the court deadline is essential for those wishing to take an active role in the case.
Source: NewsData